345 related articles for article (PubMed ID: 34075637)
1. Metabolic reprogramming of myeloid-derived suppressor cells: An innovative approach confronting challenges.
Li X; Li Y; Yu Q; Qian P; Huang H; Lin Y
J Leukoc Biol; 2021 Aug; 110(2):257-270. PubMed ID: 34075637
[TBL] [Abstract][Full Text] [Related]
2. Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor.
Yan D; Adeshakin AO; Xu M; Afolabi LO; Zhang G; Chen YH; Wan X
Front Immunol; 2019; 10():1399. PubMed ID: 31275326
[TBL] [Abstract][Full Text] [Related]
3. A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment.
Hofer F; Di Sario G; Musiu C; Sartoris S; De Sanctis F; Ugel S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685679
[TBL] [Abstract][Full Text] [Related]
4. Energy metabolism manipulates the fate and function of tumour myeloid-derived suppressor cells.
Hu C; Pang B; Lin G; Zhen Y; Yi H
Br J Cancer; 2020 Jan; 122(1):23-29. PubMed ID: 31819182
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Reprogramming of Myeloid-derived Suppressor Cells in the Tumor Microenvironment.
Liu L; Huo S; Liu J; Li Q; Wang J
Discov Med; 2021; 31(164):141-146. PubMed ID: 35188888
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Regulation of Myeloid-Derived Suppressor Cell Function in Cancer.
Wang Y; Jia A; Bi Y; Wang Y; Liu G
Cells; 2020 Apr; 9(4):. PubMed ID: 32325683
[TBL] [Abstract][Full Text] [Related]
7. A Dynamic Metabolic Flux Analysis of Myeloid-Derived Suppressor Cells Confirms Immunosuppression-Related Metabolic Plasticity.
Goffaux G; Hammami I; Jolicoeur M
Sci Rep; 2017 Aug; 7(1):9850. PubMed ID: 28852166
[TBL] [Abstract][Full Text] [Related]
8. Myeloid-Derived Suppressor Cells in Sepsis.
Schrijver IT; Théroude C; Roger T
Front Immunol; 2019; 10():327. PubMed ID: 30873175
[TBL] [Abstract][Full Text] [Related]
9. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.
Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P
Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713
[TBL] [Abstract][Full Text] [Related]
10. MDSCs in infectious diseases: regulation, roles, and readjustment.
Dorhoi A; Glaría E; Garcia-Tellez T; Nieuwenhuizen NE; Zelinskyy G; Favier B; Singh A; Ehrchen J; Gujer C; Münz C; Saraiva M; Sohrabi Y; Sousa AE; Delputte P; Müller-Trutwin M; Valledor AF
Cancer Immunol Immunother; 2019 Apr; 68(4):673-685. PubMed ID: 30569204
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine.
Yaseen MM; Abuharfeil NM; Darmani H; Daoud A
Open Biol; 2020 Sep; 10(9):200111. PubMed ID: 32931721
[TBL] [Abstract][Full Text] [Related]
12. Connections between Metabolism and Epigenetic Modification in MDSCs.
Dai H; Xu H; Wang S; Ma J
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027968
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-Derived Suppressor Cells.
Gabrilovich DI
Cancer Immunol Res; 2017 Jan; 5(1):3-8. PubMed ID: 28052991
[TBL] [Abstract][Full Text] [Related]
14. Metabolic changes and interaction of tumor cell, myeloid-derived suppressor cell and T cell in hypoxic microenvironment.
Ou X; Lv W
Future Oncol; 2020 Mar; 16(8):383-393. PubMed ID: 32067476
[TBL] [Abstract][Full Text] [Related]
15. Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment.
Schafer CC; Wang Y; Hough KP; Sawant A; Grant SC; Thannickal VJ; Zmijewski J; Ponnazhagan S; Deshane JS
Oncotarget; 2016 Nov; 7(46):75407-75424. PubMed ID: 27705910
[TBL] [Abstract][Full Text] [Related]
16. Amino Acid Transport and Metabolism in Myeloid Function.
Halaby MJ; McGaha TL
Front Immunol; 2021; 12():695238. PubMed ID: 34456909
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition: When tumor cells meet myeloid-derived suppressor cells.
Cai J; Cui Y; Yang J; Wang S
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188564. PubMed ID: 33974950
[TBL] [Abstract][Full Text] [Related]
18. Rab7 GTPase controls lipid metabolic signaling in myeloid-derived suppressor cells.
Ding X; Zhang W; Zhao T; Yan C; Du H
Oncotarget; 2017 May; 8(18):30123-30137. PubMed ID: 28415797
[TBL] [Abstract][Full Text] [Related]
19. The impact of microRNAs on myeloid-derived suppressor cells in cancer.
Baghbani E; Noorolyai S; Duijf PHG; Silvestris N; Kolahian S; Hashemzadeh S; Baghbanzadeh Kojabad A; FallahVazirabad A; Baradaran B
Hum Immunol; 2021 Sep; 82(9):668-678. PubMed ID: 34020831
[TBL] [Abstract][Full Text] [Related]
20. The diverse roles of myeloid derived suppressor cells in mucosal immunity.
Ashkenazi-Preiser H; Mikula I; Baniyash M
Cell Immunol; 2021 Jul; 365():104361. PubMed ID: 33984533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
